South Korea · Delayed Price · Currency is KRW Macrogen Company Description
Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally.
It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In Situ/spatial) services.
The company also provides whole genome, whole exome, transcriptome, epigenome, and metagenome sequencing services; standard sequencing, identification, fragment, customized sequencing, and human ID services; expression, genome, and epigenome microarray; proteomics olink; gene synthesis; DNA and RNA oligo synthesis, and peptide synthesis; and CRISPR knock-in/out, GEM, and mass production services.
Macrogen, Inc. was founded in 1997 and is based in Seoul, South Korea.
| Country | South Korea |
| Founded | 1997 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 500 |
| CEO | Changhoon Kim |
Contact Details
Address: Macrogen Bldg Seoul South Korea | |
| Phone | 82 2 2180 7000 |
| Website | macrogen.com |
Stock Details
| Ticker Symbol | 038290 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7038290003 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Changhoon Kim | Chief Executive Officer |